- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01209936
Hydration Factor Study for the Stayhealthy BC3
Pilot Study for the Validation of the BC3 Bioelectrical Impedance Hydration Factor
Study Overview
Detailed Description
The BC3 body composition analyzer is manufactured by Stayhealthy. It is a handheld, noninvasive bioelectrical impedance device. When held, the BC3 sends an electrical impulse through the body to determine body fat, lean mass, and total body hydration. Bio-impedance devices measure the change in electrical resistance in body tissues by using a detectable electrical signal that passes through the body. The method is based on the principle that lean body mass contains virtually all the water and conducting electrolytes in the body and provides a good electrical pathway. In contrast, fat or fat-containing tissues produce a poor electrical pathway. By inducing a low-energy, high-frequency signal, a measurement of the baseline resistance to flow of electrical current can be assessed. The resistance measurement relates directly to the volume of the conductor. Through repeated measurements and identifying other parameters (i.e. gender, weight, age and height) proprietary equations were developed that determine total body water, lean mass, and % body fat.
The purpose of this study is to validate the calculated hydration factor produced by the BC3 bioelectrical impedance device. If this value is valid and comparable to the gold standard (D20) then this hydration factor will offer a very quick and inexpensive method to determine total body hydration status using a hand-held bioelectrical impedance device.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Los Angeles, California, United States, 90033
- USC Clinical Exercise Research Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
• Men and women 18-80 years of age
Exclusion Criteria:
- Acute illness (infection, recent surgery, trauma).
- Pregnancy
- Pacemaker or defibrillator
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: deuterium oxide and BC3
Testing of total body water on the BC3 compared to total body water measured by deuterium oxide.
|
All participants received deuterium oxide (D2O) and testing with the BC3 for the measurement of total body water.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Estimated Body Fat % for Children Aged 10-17 Years Old
Time Frame: One time point (only one day visit)
|
Stayhealthy BC3 was analyzed against hydrostatic weighing for children aged 10-17 years old
|
One time point (only one day visit)
|
|
Percent Body Fat in Women Aged 18-80 Years Old
Time Frame: One time point (only one day visit)
|
Body fat percentage was measured via Stayhealthy BC3 as well as a full body DXA
|
One time point (only one day visit)
|
|
Estimated Percent Body Fat for Men Aged 18-80
Time Frame: One time point (only one day visit)
|
The body fat percentage as estimated from BC3 and as calculated by a full body DXA.
|
One time point (only one day visit)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Edward T Schroeder, PhD, University of Southern California
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Stayhealthy 02
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Body Composition
-
Efforia, IncRecruiting
-
Dynamical Business and Science Society - DBSS International...Universidad de Córdoba; CES University; ARTHROS Centro de Fisioterapia y EjercicioRecruiting
-
Nova Southeastern UniversityCompleted
-
Centro Universitario de Ciencias de la Salud, MexicoCompleted
-
University of Southern CaliforniaCompleted
-
University of California, San FranciscoHologic, Inc.Completed
-
University of SurreyUnknownBody Composition
-
Texas Woman's UniversityCompleted
-
Efforia, IncRecruiting
-
Efforia, IncRecruiting
Clinical Trials on D2O
-
Universidad de SonoraHospital Civil de Guadalajara; International Atomic Energy Agency; Centro de...CompletedChildhood Obesity | Childhood Cancer | Child MalnutritionMexico
-
McMaster UniversityWithdrawn
-
University of NottinghamAbbeyfieldCompletedSarcopenia | Muscle AtrophyUnited Kingdom
-
Columbia UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...RecruitingObesity | Insulin Resistance | Prediabetic State | Hyperinsulinemia | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Columbia UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...CompletedInsulin Resistance | Prediabetic State | Hyperinsulinemia | Non-Alcoholic Fatty Liver DiseaseUnited States